Anti-Jak2 antibody
Description
Application Data
Description
-
Recognises human Jak2, a non-receptor tyrosine kinase involved in immunity, cell division, cell death and tumour formation.
Application Data
-
Catalogue number crb2005683 Antibody Anti-Jak2 antibody Antigen Peptide KLH conjugated synthetic peptide crb1200892 Protein ID UniProtKB - Q62689 Aliases Tyrosine-protein kinase Jak2, Jak-2, Janus kinase 2 Cross-Reactivity Rat Host Species Rabbit Antibody Type Polyclonal Concentration 0.5 mg/mL Glycine (R1G), 0.5 mg/mL Glycine (R2G), 0.1 mg/mL TEA (R2T) Target Jak2 Family Tyr Protein Kinase family (Jak subfamily) Super Family Protein Kinase superfamily Storage This material is supplied in PBS containing 0.01% sodium azide and 1% trehalose. The product should be stored at +4°C for short term storage and -20°C for long term storage. Avoid repeated freeze/thaw cycles. References Jay et al., (2014). JAK2 Tyrosine Kinase Phosphorylates and Is Negatively Regulated by Centrosomal Protein Ninein. Mol Cell Biol, 35(1): 111. PMID:25332239.
Liu et al., (2017). Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction. Sci Rep, 7(1). PMID: 28676638.
Trivedi et al., (2018). Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis. Int J Mol Sci, 19(12): 4056. PMID: 30558204.
Janus kinase-2 (Jak2) is a non-receptor tyrosine kinase implicated in signalling via members of the type II cytokine receptor family (such as interferon receptors), the GM-CSF receptor family (IL-3R, IL-5R and GM-CSF-R), the gp130 receptor family (e.g., IL-6R), and the single chain receptors (e.g. Epo-R, Tpo-R, GH-R, PRL-R). The Jak/signal transducer and activator of transcription (STAT) pathway is a key cellular pathway involved in immunity, cell division, cell death and tumour formation. The Jak/STAT pathway is activated by leptin and the leptin receptor. It results in the phosphorylation of STAT3 and its translocation to the nucleus, where it activates the transcription of various target genes.
Mutations and gene fusions involving Jak2 have been implicated in polycythemia vera, essential thrombocythemia, myelofibrosis, other myeloproliferative disorders and leukaemia.
Anti-Jak2 antibody
You may also like…
-
Anti-Jak2 antibody
View products -
[Cys(AF647)]-Jak2/3 substrate[Cys(AF647)]-GGEEEEYFELVKK-acid
View products -
Anti-JAK3 antibody
View products -
[G]-JAK1 peptide (1015-1027) p(Y1022)GAIETDKE-[pY]-YTVKD-acid
View products -
Anti-JAK2 antibody
View products -
Anti-JAK3 antibody
View products -
Biotin-Jak2 substrateBiotin-GGEEEEYFELVKK-acid
View products -
IL-11 peptide
View products -
Anti-JAK3 antibody
View products -
IRS-1 substrate
CKKSRGDYMTMQIG-acid
View products -
[5-FAM]-IFN-γ receptor (pTyr) peptide[5-FAM]-G-[pY]-DKPH-V-L-amide
View products -
[G]-JAK1 peptide (1015-1027)GAIETDKEYYTVKD-acid
View products -
JAK2 peptide
View products -
Biotin phosphorylated JAK1 substrate peptideBiotin-CAGAGAIETDKEY-[pY]-TVKD-acid
View products -
Anti-IL23A antibody
View products -
Anti-IL-11 antibody
View products -
Jak2 substrateGGEEEEYFELVKK-acid
View products